$225.76
95911 is the lower study-count tier for 9–10 studies; 95912 is used for 11–12.
On this page
CMS RVU26D · Effective 2026-10-01
95912 Nerve conduction study Medicare reimbursement rates in Rhode Island
Reports conventional nerve conduction testing when the examination includes 11 or 12 studies to assess peripheral nerve function, conduction, or suspected nerve injury. Compare 95912 office and facility rates across CMS payment localities in Rhode Island.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 95912 in Rhode Island?
Rhode Island has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$261.23
1 of 1 localities have a supported rate.
Payment area: Rhode Island
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Electrodiagnostic testing
About 95912: Nerve conduction study, 11–12 studies
Reports conventional nerve conduction testing when the examination includes 11 or 12 studies to assess peripheral nerve function, conduction, or suspected nerve injury.
Nerve conduction studies use electrical stimulation and recording electrodes to measure how peripheral nerves conduct signals. Neurologists and physical medicine and rehabilitation physicians commonly use them to evaluate concerns such as focal nerve entrapment or generalized peripheral neuropathy. Testing may be performed in an office or hospital setting, with trained staff involved in the technical work and a qualified practitioner interpreting the findings.
Select this tier when the completed examination includes 11 or 12 qualifying nerve conduction studies; choose the tier by the study count, not simply by the number of nerves or limbs examined. The report should support the studies performed and their findings. CMS recognizes a professional component for interpretation (modifier 26) and a technical component for equipment and staff (modifier TC); reporting without either modifier represents the global service.
CMS billing rules for 95912
- Professional and technical components
- Diagnostic test with a professional component (modifier 26, interpretation) and a technical component (modifier TC, equipment and staff); billing without a modifier is the global service.
Where the value comes from
- Work RVU2.93 · 38%
- Practice expense (office) RVU4.56 · 60%
- Malpractice RVU0.14 · 2%
74K
Medicare services in 2024 · #651 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
95912 compared with similar codes
Office rates for Rhode Island, from the same CMS release.
$307.46
95913 is for examinations with 13 or more studies. Use 95912 when the total is 11 or 12.
$34.39
95905 describes automated nerve conduction testing, rather than selecting a conventional study-count tier such as 95912.
$102.63
95886 describes needle EMG of an extremity, not nerve conduction studies; both may be reported when each service is performed.
Compare 95912 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Rhode Island →
Office / nonfacility
$261.23
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 95912 in Rhode Island.
PPRRVU2026_Oct_nonQPP.csv
12,645
- Code
- 95912
- Physician work
- 2.93
- Practice expense
- 4.56
- Malpractice
- 0.14
GPCI2026.csv
92
- Locality
- Rhode Island
- Physician work
- 1.019
- Practice expense
- 1.033
- Malpractice
- 0.892
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 2.93 | × 1.019 | 2.9857 |
| Practice expense | 4.56 | × 1.033 | 4.7105 |
| Malpractice | 0.14 | × 0.892 | 0.1249 |
| Total RVUs | 7.8210 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Rhode Island$261.23
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 2.93 | 1.019 |
| Practice expense | 4.56 | 1.033 |
| Malpractice | 0.14 | 0.892 |
(2.93 × 1.019 + 4.56 × 1.033 + 0.14 × 0.892) × $33.4009 = $261.23
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
95912 billing questions
When should 95912 be chosen instead of 95911 or 95913?
Use 95912 when the examination includes 11 or 12 qualifying nerve conduction studies. The adjacent tiers are for 9–10 studies and 13 or more studies, respectively.
Is 95912 reported once per nerve or once per study?
Choose one code from the nerve conduction study series based on the total qualifying study count. Do not treat the tier as a separate unit for each nerve or limb.
Can nerve conduction testing and needle EMG be reported together?
They represent distinct electrodiagnostic services. When needle EMG is performed and documented, it may be reported with the applicable EMG code.
What do modifiers 26 and TC indicate for 95912?
Modifier 26 identifies the professional interpretation, while TC identifies the technical service, including equipment and staff. Without either modifier, the claim represents the global service.
What documentation supports reporting 95912?
Document the studies performed, the results, and the interpretation. The record should support a total of 11 or 12 qualifying studies.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
12,64295911,,Nrv cndj test 9-10 studies,A,,2.44,4.05,,4.05,NA,0.10,6.59,6.59,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64395911,26,Nrv cndj test 9-10 studies,A,,2.44,1.44,,1.44,,0.09,3.97,3.97,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64495911,TC,Nrv cndj test 9-10 studies,A,,0.00,2.61,,2.61,NA,0.01,2.62,2.62,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64595912,,Nrv cndj test 11-12 studies,A,,2.93,4.56,,4.56,NA,0.14,7.63,7.63,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64695912,26,Nrv cndj test 11-12 studies,A,,2.93,1.69,,1.69,,0.12,4.74,4.74,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64795912,TC,Nrv cndj test 11-12 studies,A,,0.00,2.87,,2.87,NA,0.02,2.89,2.89,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,64895913,,Nrv cndj test 13/> studies,A,,3.47,5.35,,5.35,NA,0.16,8.98,8.98,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
8912502,PA,01,METROPOLITAN PHILADELPHIA,1.018,1.041,1.193
9012502,PA,99,REST OF PENNSYLVANIA,1.000,0.918,0.945
9109202,PR,20,PUERTO RICO,1.000,1.011,0.985
9214412,RI,01,RHODE ISLAND,1.019,1.033,0.892
9311202,SC,01,SOUTH CAROLINA,1.000,0.924,0.850
9403402,SD,02,SOUTH DAKOTA**,1.000,1.000,0.336
9510312,TN,35,TENNESSEE,1.000,0.909,0.537